Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Cumulative Effect Period of Adoption Adjusted Balance
Preferred Stock
Common Stock
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock
Additional Paid-in- Capital
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in- Capital
Treasury Stock
Cumulative Effect Period of Adoption Adjusted Balance
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Accumulated Deficit
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Total
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption $ 3 $ 3 $ 38 $ 38 $ 183,139 $ 183,139 $ (7,146) $ (7,146) $ 579 $ 579 $ 1,623 $ (136,168) $ (137,791) $ 1,623 $ 40,445 $ 38,822
Balance as currently reported at, December 29, 2018 (in shares) 2,771   34,992                          
Beginning balance (in shares) at Dec. 29, 2018   2,771   34,992                        
Beginning balance at Dec. 29, 2018 $ 3 $ 3 $ 38 $ 38 183,139 183,139 (7,146) (7,146) 579 579 1,623 (136,168) (137,791) 1,623 40,445 38,822
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption 3 $ 3 38 $ 38 183,139 183,409 (7,146) (7,146) 579 574 1,623 (136,168) (139,788) 1,623 40,445 37,090
Net income (loss)                         (3,581)     (3,581)
Issuance of shares in connection with restricted stock units vesting           (288)                   (288)
Issuance of shares in connection with restricted stock units vesting (in shares)       437                        
Issuance of shares in connection with BOD Fees           4                   4
Issuance of shares in connection with BOD Fees (in shares)       4                        
Share-based compensation           554                   554
Common stock dividend on preferred stock                         (39)     (39)
Effect of changes in foreign currencies                   (5)           (5)
Ending balance (in shares) at Mar. 30, 2019   2,771   35,433                        
Ending balance at Mar. 30, 2019   $ 3   $ 38   183,409   (7,146)   574     (139,788)     37,090
Beginning balance (in shares) at Dec. 29, 2018   2,771   34,992                        
Beginning balance at Dec. 29, 2018 3 $ 3 38 $ 38 183,139 183,139 (7,146) (7,146) 579 579 1,623 (136,168) (137,791) 1,623 40,445 38,822
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption $ 3 $ 3 $ 38 $ 38 $ 183,139 185,033 $ (7,146) (7,146) $ 579 560 $ 1,623 $ (136,168) (142,750) $ 1,623 $ 40,445 35,738
Net income (loss)                               (6,461)
Ending balance (in shares) at Sep. 28, 2019   2,771   35,924                        
Ending balance at Sep. 28, 2019   $ 3   $ 38   185,033   (7,146)   560     (142,750)     35,738
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   $ 3   $ 38   183,409   (7,146)   574     (139,788)     37,090
Beginning balance (in shares) at Mar. 30, 2019   2,771   35,433                        
Beginning balance at Mar. 30, 2019   $ 3   $ 38   183,409   (7,146)   574     (139,788)     37,090
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   $ 3   $ 38   184,077   (7,146)   541     (141,286)     36,227
Net income (loss)                         (1,457)     (1,457)
Issuance of shares in connection with restricted stock units vesting           (2)                   (2)
Issuance of shares in connection with restricted stock units vesting (in shares)       348                        
Issuance of shares in connection with BOD Fees           5                   5
Issuance of shares in connection with BOD Fees (in shares)       3                        
Share-based compensation           625                   625
Common stock dividend on preferred stock           40             (41)     (1)
Effect of changes in foreign currencies                   (33)           (33)
Ending balance (in shares) at Jun. 29, 2019   2,771   35,784                        
Ending balance at Jun. 29, 2019   $ 3   $ 38   184,077   (7,146)   541     (141,286)     36,227
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   3   38   184,077   (7,146)   541     (141,286)     36,227
Effect of new accounting adoption   $ 3   $ 38   185,033   (7,146)   560     (142,750)     35,738
Net income (loss)                         (1,424)     (1,424)
Issuance of shares in connection with stock option exercise           100                   100
Issuance of shares in connection with stock option exercises (in shares)       100                        
Issuance of shares in connection with restricted stock units vesting           (2)                   (2)
Issuance of shares in connection with restricted stock units vesting (in shares)       2                        
Issuance of shares in connection with BOD Fees           5                   5
Issuance of shares in connection with BOD Fees (in shares)       5                        
Share-based compensation           813                   813
Common stock dividend on preferred stock           40             (40)      
Common stock dividend on preferred stock (in shares)       33                        
Effect of changes in foreign currencies                   19           19
Ending balance (in shares) at Sep. 28, 2019   2,771   35,924                        
Ending balance at Sep. 28, 2019   $ 3   $ 38   185,033   (7,146)   560     (142,750)     35,738
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   3   38   185,033   (7,146)   560     (142,750)     35,738
Effect of new accounting adoption   $ 3   $ 38   187,147   (7,146)   214     (167,876)     12,380
Beginning balance (in shares) at Dec. 28, 2019   2,771   36,167                        
Beginning balance at Dec. 28, 2019   $ 3   $ 38   187,147   (7,146)   214     (167,876)     12,380
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   $ 3   41   191,043   (7,146)   113     (168,893)     15,161
Net income (loss)                         (978)     (978)
Issuance of shares in connection with stock option exercise       $ 1   1,119                   1,120
Issuance of shares in connection with stock option exercises (in shares)       523                        
Issuance of shares in connection with restricted stock units vesting       $ 2   (86)                   (84)
Issuance of shares in connection with restricted stock units vesting (in shares)       1,809                        
Issuance of shares in connection with BOD Fees           6                   6
Issuance of shares in connection with BOD Fees (in shares)       3                        
Share-based compensation           2,819                   2,819
Common stock dividend on preferred stock           38             (39)     (1)
Common stock dividend on preferred stock (in shares)       20                        
Conversion of preferred stock (in shares)   (150)   150                        
Unrealized gain (loss) on deferred compensation trust assets                   (95)           (95)
Effect of changes in foreign currencies                   (6)           (6)
Ending balance (in shares) at Mar. 28, 2020   2,621   38,672                        
Ending balance at Mar. 28, 2020   $ 3   $ 41   191,043   (7,146)   113     (168,893)     15,161
Beginning balance (in shares) at Dec. 28, 2019   2,771   36,167                        
Beginning balance at Dec. 28, 2019   $ 3   $ 38   187,147   (7,146)   214     (167,876)     12,380
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   3   $ 50   257,497   (7,146)   139     (165,973)     84,567
Net income (loss)                               $ 1,975
Issuance of shares in connection with stock option exercises (in shares)                               1,793
Unrealized gain (loss) on deferred compensation trust assets                               $ (2)
Ending balance (in shares) at Sep. 26, 2020       47,772                        
Ending balance at Sep. 26, 2020       $ 50   257,497   (7,146)   139     (165,973)     84,567
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   $ 3   $ 41   191,043   (7,146)   113     (168,893)     15,161
Beginning balance (in shares) at Mar. 28, 2020   2,621   38,672                        
Beginning balance at Mar. 28, 2020   $ 3   $ 41   191,043   (7,146)   113     (168,893)     15,161
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   3   45   194,693   (7,146)   142     (167,358)     20,376
Net income (loss)                         1,568     1,568
Issuance of shares in connection with stock option exercise       $ 1   1,772                   1,773
Issuance of shares in connection with stock option exercises (in shares)       907                        
Issuance of shares in connection with restricted stock units vesting           (2)                   (2)
Issuance of shares in connection with restricted stock units vesting (in shares)       183                        
Issuance of shares in connection with BOD Fees           6                   6
Issuance of shares in connection with BOD Fees (in shares)       3                        
Share-based compensation           1,874                   1,874
Common stock dividend on preferred stock                         (33)     (33)
Common stock dividend on preferred stock (in shares)       25                        
Conversion of preferred stock   $ (3)   $ 3                        
Conversion of preferred stock (in shares)   (2,621)   2,621                        
Unrealized gain (loss) on deferred compensation trust assets                   58           58
Effect of changes in foreign currencies                   (29)           (29)
Ending balance (in shares) at Jun. 27, 2020       42,411                        
Ending balance at Jun. 27, 2020       $ 45   194,693   (7,146)   142     (167,358)     20,376
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption       45   194,693   (7,146)   142     (167,358)     20,376
Effect of new accounting adoption       50   257,497   (7,146)   139     (165,973)     84,567
Net income (loss)                         1,385     1,385
Issuance of common stock, net of underwriters' offering expenses and commissions       $ 5   60,526                   60,531
Issuance of common stock, net of underwriters' offering expenses and commissions (in shares)       4,900                        
Issuance of shares in connection with stock option exercise           504                   504
Issuance of shares in connection with stock option exercises (in shares)       459                        
Issuance of shares in connection with restricted stock units vesting           (5)                   (5)
Issuance of shares in connection with restricted stock units vesting (in shares)       1                        
Issuance of shares in connection with BOD Fees           6                   6
Issuance of shares in connection with BOD Fees (in shares)       1                        
Share-based compensation           1,773                   1,773
Unrealized gain (loss) on deferred compensation trust assets                   35           35
Effect of changes in foreign currencies                   (38)           (38)
Ending balance (in shares) at Sep. 26, 2020       47,772                        
Ending balance at Sep. 26, 2020       $ 50   257,497   (7,146)   139     (165,973)     84,567
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption       $ 50   $ 257,497   $ (7,146)   $ 139     $ (165,973)     $ 84,567